Craig A.Tooman

2013

In 2013, Craig A.Tooman earned a total compensation of $2.2M as Chief Financial Officer at Aratana Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$17,500
Option Awards$1,159,535
Salary$88,504
Stock Awards$941,787
Other$1,167
Total$2,208,493

ATooman received $1.2M in option awards, accounting for 53% of the total pay in 2013.

ATooman also received $17.5K in non-equity incentive plan, $88.5K in salary, $941.8K in stock awards and $1.2K in other compensation.

Rankings

In 2013, Craig A.Tooman's compensation ranked 3,554th out of 12,286 executives tracked by ExecPay. In other words, ATooman earned more than 71.1% of executives.

ClassificationRankingPercentile
All
3,554
out of 12,286
71st
Division
Manufacturing
1,203
out of 4,612
74th
Major group
Chemicals And Allied Products
328
out of 1,462
78th
Industry group
Drugs
229
out of 1,156
80th
Industry
Pharmaceutical Preparations
187
out of 890
79th
Source: SEC filing on April 28, 2015.

ATooman's colleagues

We found four more compensation records of executives who worked with Craig A.Tooman at Aratana Therapeutics in 2013.

2013

Steven Peter

Aratana Therapeutics

Chief Executive Officer

2013

Julia Stephanus

Aratana Therapeutics

Chief Commercial Officer

2013

Ernst Heinen

Aratana Therapeutics

Chief Development Officer

2013

Linda Rhodes

Aratana Therapeutics

Chief Scientific Officer

In-depth

You may also like